iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes episode artwork

EPISODE · May 24, 2023 · 11 MIN

iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes

from VJHemOnc Podcast · host VJHemOnc

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in chronic lymphocytic leukemia (CLL), lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and more. In this podcast, you will hear from David Sallman, MD, Moffitt Cancer Center, Tampa, FL, Marion Subklewe, MD, Ludwig-Maximilians University, Munich, Germany, and Roman Shapiro, MD, Dana-Farber Cancer Institute, Boston, MA, who discuss major challenges with CAR-T therapy in AML, strategies to improve outcomes for patients, and more. 

Episode metadata supplied by the publisher feed · Published May 24, 2023

Embed this episode

NOW PLAYING

iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes

0:00 11:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of VJHemOnc Podcast?

This episode is 11 minutes long.

When was this VJHemOnc Podcast episode published?

This episode was published on May 24, 2023.

Can I download this VJHemOnc Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!